Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Ofatumumab versus Teriflunomide in Multiple Sclerosis..
N Engl J Med. 383(6), 546-557.
(2020).
(2020).
(2019).
Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis..
Blood Cancer J. 7(8), e597.
(2017). The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation..
Eur J Dermatol. 26(6), 566-571.
(2016). Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis..
Genes Chromosomes Cancer. 54(4), 210-21.
(2015). TACI expression and signaling in chronic lymphocytic leukemia..
J Immunol Res. 2015, 478753.
(2015). Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma..
Proc Natl Acad Sci U S A. 111(42), E4513-22.
(2014). Inhibition of indoleamine 2,3-dioxygenase not only blocks autoreactive B cell activation, but it also reduces production of antibodies in general: comment on the article by Pigott and Mandik-Nayak..
Arthritis Rheum. 65(7), 1951-2.
(2013). Mechanism of Polycomb recruitment to CpG islands revealed by inherited disease-associated mutation..
Hum Mol Genet. 22(16), 3187-94.
(2013). An unusual case of biphenotypic, bigenotypic mature lymphoma..
J Clin Pathol. 66(12), 1090-2.
(2013). Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma..
Ann Hematol. 91(7), 1157-9.
(2012). Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome..
J Pediatr. 161(5), 950-3.
(2012). Response to rituximab and timeframe to relapse in rheumatoid arthritis patients: association with B-cell markers..
Mol Diagn Ther. 14(1), 43-8.
(2010). Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma..
Int J Cancer. 125(10), 2367-74.
(2009).
(2009).